SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '5ohj'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1G5Y_B_9CRB501_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	5 / 12	ILE A 367 ALA A 415 LEU A 422 LEU A 377 ILE A 371	None	1.24A	1g5yB-5ohjA: undetectable	1g5yB-5ohjA: 19.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1GSE_A_EAAA224_1 (GLUTATHIONE TRANSFERASE)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	5 / 12	ARG A 375 LEU A 437 LEU A 506 VAL A 510 ALA A 444	None	1.04A	1gseA-5ohjA: undetectable	1gseA-5ohjA: 15.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QKU_A_ESTA600_1 (ESTRADIOL RECEPTOR)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	5 / 10	ALA A 563 LEU A 421 LEU A 422 MET A 368 ILE A 371	None	1.08A	1qkuA-5ohjA: undetectable	1qkuA-5ohjA: 17.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QKU_B_ESTB600_1 (ESTRADIOL RECEPTOR)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	5 / 10	ALA A 563 LEU A 421 LEU A 422 MET A 368 ILE A 371	None	1.07A	1qkuB-5ohjA: 1.9	1qkuB-5ohjA: 17.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QKU_C_ESTC600_1 (ESTRADIOL RECEPTOR)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	5 / 10	ALA A 563 LEU A 421 LEU A 422 MET A 368 ILE A 371	None	1.08A	1qkuC-5ohjA: 1.9	1qkuC-5ohjA: 17.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1UHO_A_VDNA1000_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	6 / 10	TYR A 405 HIS A 406 PHE A 586 GLN A 615 GLY A 617 PHE A 618	None None 9VE A 801 (-3.6A) 9VE A 801 (-3.2A) None 9VE A 801 (-3.9A)	0.34A	1uhoA-5ohjA: 36.4	1uhoA-5ohjA: 12.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XLX_A_CIOA101_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	5 / 12	HIS A 446 MET A 519 THR A 579 GLN A 615 PHE A 618	ZN A 699 (-3.2A) 9VE A 801 (-3.8A) 9VE A 801 (-4.1A) 9VE A 801 (-3.2A) 9VE A 801 (-3.9A)	1.43A	1xlxA-5ohjA: 52.6	1xlxA-5ohjA: 11.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XLX_A_CIOA101_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	12 / 12	TYR A 405 HIS A 406 HIS A 450 MET A 519 LEU A 565 ASN A 567 THR A 579 ILE A 582 MET A 583 SER A 614 GLN A 615 PHE A 618	None None None 9VE A 801 (-3.8A) 9VE A 801 (-4.7A) 9VE A 801 (-4.1A) 9VE A 801 (-4.1A) 9VE A 801 (-4.1A) 9VE A 801 ( 4.0A) 9VE A 801 (-4.7A) 9VE A 801 (-3.2A) 9VE A 801 (-3.9A)	0.36A	1xlxA-5ohjA: 52.6	1xlxA-5ohjA: 11.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XLX_B_CIOB102_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	8 / 12	HIS A 406 HIS A 450 MET A 519 MET A 583 PHE A 586 MET A 603 SER A 614 PHE A 618	None None 9VE A 801 (-3.8A) 9VE A 801 ( 4.0A) 9VE A 801 (-3.6A) 9VE A 801 (-3.6A) 9VE A 801 (-4.7A) 9VE A 801 (-3.9A)	0.94A	1xlxB-5ohjA: 52.6	1xlxB-5ohjA: 11.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XLX_B_CIOB102_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	5 / 12	HIS A 446 MET A 519 THR A 579 GLN A 615 PHE A 618	ZN A 699 (-3.2A) 9VE A 801 (-3.8A) 9VE A 801 (-4.1A) 9VE A 801 (-3.2A) 9VE A 801 (-3.9A)	1.44A	1xlxB-5ohjA: 52.6	1xlxB-5ohjA: 11.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XLX_B_CIOB102_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	11 / 12	TYR A 405 HIS A 406 HIS A 450 MET A 519 THR A 579 ILE A 582 MET A 583 PHE A 586 MET A 603 GLN A 615 PHE A 618	None None None 9VE A 801 (-3.8A) 9VE A 801 (-4.1A) 9VE A 801 (-4.1A) 9VE A 801 ( 4.0A) 9VE A 801 (-3.6A) 9VE A 801 (-3.6A) 9VE A 801 (-3.2A) 9VE A 801 (-3.9A)	0.62A	1xlxB-5ohjA: 52.6	1xlxB-5ohjA: 11.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XMU_A_ROFA101_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	11 / 12	TYR A 405 HIS A 406 ASP A 564 LEU A 565 PRO A 568 TYR A 575 TRP A 578 ILE A 582 PHE A 586 SER A 614 PHE A 618	None None ZN A 699 ( 2.6A) 9VE A 801 (-4.7A) 9VE A 801 (-3.9A) 9VE A 801 (-4.6A) None 9VE A 801 (-4.1A) 9VE A 801 (-3.6A) 9VE A 801 (-4.7A) 9VE A 801 (-3.9A)	0.26A	1xmuA-5ohjA: 53.3	1xmuA-5ohjA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XMU_A_ROFA101_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	8 / 12	TYR A 405 LEU A 565 PRO A 568 TYR A 575 TRP A 578 ILE A 582 MET A 603 PHE A 618	None 9VE A 801 (-4.7A) 9VE A 801 (-3.9A) 9VE A 801 (-4.6A) None 9VE A 801 (-4.1A) 9VE A 801 (-3.6A) 9VE A 801 (-3.9A)	0.67A	1xmuA-5ohjA: 53.3	1xmuA-5ohjA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XMU_A_ROFA101_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	5 / 5	MET A 519 ASN A 567 THR A 579 MET A 583 GLN A 615	9VE A 801 (-3.8A) 9VE A 801 (-4.1A) 9VE A 801 (-4.1A) 9VE A 801 ( 4.0A) 9VE A 801 (-3.2A)	0.28A	1xmuA-5ohjA: 53.3	1xmuA-5ohjA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XMU_B_ROFB102_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	11 / 12	TYR A 405 HIS A 406 MET A 519 ASP A 564 LEU A 565 PRO A 568 TYR A 575 TRP A 578 ILE A 582 PHE A 586 SER A 614	None None 9VE A 801 (-3.8A) ZN A 699 ( 2.6A) 9VE A 801 (-4.7A) 9VE A 801 (-3.9A) 9VE A 801 (-4.6A) None 9VE A 801 (-4.1A) 9VE A 801 (-3.6A) 9VE A 801 (-4.7A)	0.30A	1xmuB-5ohjA: 52.8	1xmuB-5ohjA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XMU_B_ROFB102_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	10 / 12	TYR A 405 MET A 519 ASP A 564 LEU A 565 PRO A 568 TYR A 575 TRP A 578 ILE A 582 MET A 603 SER A 614	None 9VE A 801 (-3.8A) ZN A 699 ( 2.6A) 9VE A 801 (-4.7A) 9VE A 801 (-3.9A) 9VE A 801 (-4.6A) None 9VE A 801 (-4.1A) 9VE A 801 (-3.6A) 9VE A 801 (-4.7A)	0.65A	1xmuB-5ohjA: 52.8	1xmuB-5ohjA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XMU_B_ROFB102_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	5 / 5	ASN A 567 THR A 579 MET A 583 GLN A 615 PHE A 618	9VE A 801 (-4.1A) 9VE A 801 (-4.1A) 9VE A 801 ( 4.0A) 9VE A 801 (-3.2A) 9VE A 801 (-3.9A)	0.15A	1xmuB-5ohjA: 52.8	1xmuB-5ohjA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOM_A_CIOA603_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	6 / 12	TYR A 405 ASP A 447 ILE A 582 MET A 583 PHE A 586 MET A 603	None MG A 700 ( 2.7A) 9VE A 801 (-4.1A) 9VE A 801 ( 4.0A) 9VE A 801 (-3.6A) 9VE A 801 (-3.6A)	1.41A	1xomA-5ohjA: 52.6	1xomA-5ohjA: 11.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOM_A_CIOA603_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	11 / 12	TYR A 405 HIS A 406 MET A 519 ASP A 564 LEU A 565 ILE A 582 MET A 583 PHE A 586 MET A 603 GLN A 615 PHE A 618	None None 9VE A 801 (-3.8A) ZN A 699 ( 2.6A) 9VE A 801 (-4.7A) 9VE A 801 (-4.1A) 9VE A 801 ( 4.0A) 9VE A 801 (-3.6A) 9VE A 801 (-3.6A) 9VE A 801 (-3.2A) 9VE A 801 (-3.9A)	0.59A	1xomA-5ohjA: 52.6	1xomA-5ohjA: 11.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOM_A_CIOA603_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	11 / 12	TYR A 405 HIS A 406 MET A 519 ASP A 564 LEU A 565 ILE A 582 MET A 583 PHE A 586 SER A 614 GLN A 615 PHE A 618	None None 9VE A 801 (-3.8A) ZN A 699 ( 2.6A) 9VE A 801 (-4.7A) 9VE A 801 (-4.1A) 9VE A 801 ( 4.0A) 9VE A 801 (-3.6A) 9VE A 801 (-4.7A) 9VE A 801 (-3.2A) 9VE A 801 (-3.9A)	0.27A	1xomA-5ohjA: 52.6	1xomA-5ohjA: 11.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOM_B_CIOB601_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	11 / 12	TYR A 405 HIS A 406 MET A 519 LEU A 565 THR A 579 ILE A 582 MET A 583 PHE A 586 MET A 603 GLN A 615 PHE A 618	None None 9VE A 801 (-3.8A) 9VE A 801 (-4.7A) 9VE A 801 (-4.1A) 9VE A 801 (-4.1A) 9VE A 801 ( 4.0A) 9VE A 801 (-3.6A) 9VE A 801 (-3.6A) 9VE A 801 (-3.2A) 9VE A 801 (-3.9A)	0.58A	1xomB-5ohjA: 52.1	1xomB-5ohjA: 11.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOM_B_CIOB601_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	11 / 12	TYR A 405 HIS A 406 MET A 519 LEU A 565 THR A 579 ILE A 582 MET A 583 PHE A 586 SER A 614 GLN A 615 PHE A 618	None None 9VE A 801 (-3.8A) 9VE A 801 (-4.7A) 9VE A 801 (-4.1A) 9VE A 801 (-4.1A) 9VE A 801 ( 4.0A) 9VE A 801 (-3.6A) 9VE A 801 (-4.7A) 9VE A 801 (-3.2A) 9VE A 801 (-3.9A)	0.29A	1xomB-5ohjA: 52.1	1xomB-5ohjA: 11.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOM_B_CIOB601_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	7 / 12	TYR A 405 HIS A 410 MET A 519 LEU A 565 THR A 579 GLN A 615 PHE A 618	None ZN A 699 (-3.3A) 9VE A 801 (-3.8A) 9VE A 801 (-4.7A) 9VE A 801 (-4.1A) 9VE A 801 (-3.2A) 9VE A 801 (-3.9A)	1.47A	1xomB-5ohjA: 52.1	1xomB-5ohjA: 11.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOQ_A_ROFA502_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	11 / 12	TYR A 405 HIS A 406 MET A 519 ASP A 564 LEU A 565 PRO A 568 TYR A 575 THR A 579 ILE A 582 SER A 614 PHE A 618	None None 9VE A 801 (-3.8A) ZN A 699 ( 2.6A) 9VE A 801 (-4.7A) 9VE A 801 (-3.9A) 9VE A 801 (-4.6A) 9VE A 801 (-4.1A) 9VE A 801 (-4.1A) 9VE A 801 (-4.7A) 9VE A 801 (-3.9A)	0.25A	1xoqA-5ohjA: 52.6	1xoqA-5ohjA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOQ_A_ROFA502_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	9 / 12	TYR A 405 LEU A 565 PRO A 568 TYR A 575 THR A 579 ILE A 582 MET A 603 SER A 614 PHE A 618	None 9VE A 801 (-4.7A) 9VE A 801 (-3.9A) 9VE A 801 (-4.6A) 9VE A 801 (-4.1A) 9VE A 801 (-4.1A) 9VE A 801 (-3.6A) 9VE A 801 (-4.7A) 9VE A 801 (-3.9A)	0.56A	1xoqA-5ohjA: 52.6	1xoqA-5ohjA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOQ_A_ROFA502_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	3 / 3	ASN A 567 TRP A 578 GLN A 615	9VE A 801 (-4.1A) None 9VE A 801 (-3.2A)	0.10A	1xoqA-5ohjA: 52.6	1xoqA-5ohjA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOQ_B_ROFB501_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	11 / 12	TYR A 405 HIS A 406 ASP A 564 LEU A 565 PRO A 568 TYR A 575 TRP A 578 THR A 579 ILE A 582 SER A 614 PHE A 618	None None ZN A 699 ( 2.6A) 9VE A 801 (-4.7A) 9VE A 801 (-3.9A) 9VE A 801 (-4.6A) None 9VE A 801 (-4.1A) 9VE A 801 (-4.1A) 9VE A 801 (-4.7A) 9VE A 801 (-3.9A)	0.15A	1xoqB-5ohjA: 51.9	1xoqB-5ohjA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOQ_B_ROFB501_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	9 / 12	TYR A 405 LEU A 565 PRO A 568 TYR A 575 TRP A 578 THR A 579 ILE A 582 MET A 603 PHE A 618	None 9VE A 801 (-4.7A) 9VE A 801 (-3.9A) 9VE A 801 (-4.6A) None 9VE A 801 (-4.1A) 9VE A 801 (-4.1A) 9VE A 801 (-3.6A) 9VE A 801 (-3.9A)	0.55A	1xoqB-5ohjA: 51.9	1xoqB-5ohjA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOQ_B_ROFB501_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	3 / 3	MET A 519 ASN A 567 GLN A 615	9VE A 801 (-3.8A) 9VE A 801 (-4.1A) 9VE A 801 (-3.2A)	0.31A	1xoqB-5ohjA: 51.9	1xoqB-5ohjA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOS_A_VIAA1_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	11 / 12	TYR A 405 HIS A 406 MET A 519 ASP A 564 LEU A 565 MET A 583 PHE A 586 MET A 603 GLN A 615 PHE A 618 ILE A 622	None None 9VE A 801 (-3.8A) ZN A 699 ( 2.6A) 9VE A 801 (-4.7A) 9VE A 801 ( 4.0A) 9VE A 801 (-3.6A) 9VE A 801 (-3.6A) 9VE A 801 (-3.2A) 9VE A 801 (-3.9A) 9VE A 801 (-4.8A)	0.61A	1xosA-5ohjA: 52.1	1xosA-5ohjA: 11.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOS_A_VIAA1_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	7 / 12	TYR A 405 HIS A 406 MET A 519 ASP A 564 MET A 583 PHE A 586 SER A 601	None None 9VE A 801 (-3.8A) ZN A 699 ( 2.6A) 9VE A 801 ( 4.0A) 9VE A 801 (-3.6A) None	1.21A	1xosA-5ohjA: 52.1	1xosA-5ohjA: 11.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOS_A_VIAA1_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	7 / 12	TYR A 405 HIS A 410 MET A 519 LEU A 565 GLN A 615 PHE A 618 ILE A 622	None ZN A 699 (-3.3A) 9VE A 801 (-3.8A) 9VE A 801 (-4.7A) 9VE A 801 (-3.2A) 9VE A 801 (-3.9A) 9VE A 801 (-4.8A)	1.46A	1xosA-5ohjA: 52.1	1xosA-5ohjA: 11.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOT_A_VDNA101_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	12 / 12	TYR A 405 HIS A 406 MET A 519 LEU A 565 ILE A 582 MET A 583 SER A 601 MET A 603 SER A 614 GLN A 615 PHE A 618 ILE A 622	None None 9VE A 801 (-3.8A) 9VE A 801 (-4.7A) 9VE A 801 (-4.1A) 9VE A 801 ( 4.0A) None 9VE A 801 (-3.6A) 9VE A 801 (-4.7A) 9VE A 801 (-3.2A) 9VE A 801 (-3.9A) 9VE A 801 (-4.8A)	0.92A	1xotA-5ohjA: 52.6	1xotA-5ohjA: 11.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOT_B_VDNB102_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	8 / 12	HIS A 406 MET A 519 LEU A 565 MET A 583 SER A 601 MET A 603 SER A 614 PHE A 618	None 9VE A 801 (-3.8A) 9VE A 801 (-4.7A) 9VE A 801 ( 4.0A) None 9VE A 801 (-3.6A) 9VE A 801 (-4.7A) 9VE A 801 (-3.9A)	0.91A	1xotB-5ohjA: 52.6	1xotB-5ohjA: 11.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOT_B_VDNB102_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	11 / 12	TYR A 405 HIS A 406 MET A 519 LEU A 565 ASN A 567 ILE A 582 MET A 583 SER A 601 MET A 603 GLN A 615 PHE A 618	None None 9VE A 801 (-3.8A) 9VE A 801 (-4.7A) 9VE A 801 (-4.1A) 9VE A 801 (-4.1A) 9VE A 801 ( 4.0A) None 9VE A 801 (-3.6A) 9VE A 801 (-3.2A) 9VE A 801 (-3.9A)	0.64A	1xotB-5ohjA: 52.6	1xotB-5ohjA: 11.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2H42_A_VIAA901_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	5 / 11	TYR A 405 HIS A 406 PHE A 586 GLN A 615 PHE A 618	None None 9VE A 801 (-3.6A) 9VE A 801 (-3.2A) 9VE A 801 (-3.9A)	0.37A	2h42A-5ohjA: 36.2	2h42A-5ohjA: 13.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2H42_C_VIAC903_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	5 / 12	TYR A 405 LEU A 565 PHE A 586 GLN A 615 PHE A 618	None 9VE A 801 (-4.7A) 9VE A 801 (-3.6A) 9VE A 801 (-3.2A) 9VE A 801 (-3.9A)	0.56A	2h42C-5ohjA: 35.9	2h42C-5ohjA: 13.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2JFA_A_RALA600_1 (ESTROGEN RECEPTOR)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	5 / 12	ALA A 563 TRP A 348 LEU A 421 LEU A 422 MET A 368	None	1.10A	2jfaA-5ohjA: 2.1	2jfaA-5ohjA: 15.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2JFA_B_RALB600_1 (ESTROGEN RECEPTOR)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	5 / 12	ALA A 563 TRP A 348 LEU A 421 LEU A 422 MET A 368	None	1.12A	2jfaB-5ohjA: 2.0	2jfaB-5ohjA: 15.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2WEY_A_EV1A1771_1 (CAMP AND CAMP-INHIBITED CGMP 3', 5'-CYCLIC PHOSPHODIESTERASE)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	9 / 12	TYR A 405 HIS A 406 LEU A 565 ILE A 582 GLU A 585 PHE A 586 MET A 603 GLN A 615 PHE A 618	None None 9VE A 801 (-4.7A) 9VE A 801 (-4.1A) None 9VE A 801 (-3.6A) 9VE A 801 (-3.6A) 9VE A 801 (-3.2A) 9VE A 801 (-3.9A)	1.04A	2weyA-5ohjA: 37.9	2weyA-5ohjA: 11.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2YJA_B_ESTB1550_1 (ESTROGEN RECEPTOR)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	5 / 12	ALA A 563 LEU A 421 LEU A 422 MET A 368 ILE A 371	None	1.12A	2yjaB-5ohjA: 3.0	2yjaB-5ohjA: 16.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ARR_A_PNXA607_1 (CHITINASE A)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	4 / 7	VAL A 414 SER A 566 THR A 418 LEU A 421	None	1.21A	3arrA-5ohjA: undetectable	3arrA-5ohjA: 10.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B2R_A_VDNA1_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	6 / 12	TYR A 405 HIS A 406 LEU A 565 PHE A 586 GLN A 615 PHE A 618	None None 9VE A 801 (-4.7A) 9VE A 801 (-3.6A) 9VE A 801 (-3.2A) 9VE A 801 (-3.9A)	0.68A	3b2rA-5ohjA: 31.5	3b2rA-5ohjA: 13.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B2R_B_VDNB1_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	5 / 11	TYR A 405 HIS A 406 LEU A 565 GLN A 615 PHE A 618	None None 9VE A 801 (-4.7A) 9VE A 801 (-3.2A) 9VE A 801 (-3.9A)	0.69A	3b2rB-5ohjA: 31.5	3b2rB-5ohjA: 13.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3CZV_A_AZMA263_1 (CARBONIC ANHYDRASE 13)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	5 / 12	HIS A 410 HIS A 446 PHE A 618 THR A 517 VAL A 623	ZN A 699 (-3.3A) ZN A 699 (-3.2A) 9VE A 801 (-3.9A) None None	1.11A	3czvA-5ohjA: undetectable 3czvB-5ohjA: undetectable	3czvA-5ohjA: 14.92 3czvB-5ohjA: 14.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3G4L_A_ROFA901_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	9 / 12	TYR A 405 ASN A 567 PRO A 568 TYR A 575 TRP A 578 THR A 579 ILE A 582 MET A 603 PHE A 618	None 9VE A 801 (-4.1A) 9VE A 801 (-3.9A) 9VE A 801 (-4.6A) None 9VE A 801 (-4.1A) 9VE A 801 (-4.1A) 9VE A 801 (-3.6A) 9VE A 801 (-3.9A)	0.68A	3g4lA-5ohjA: 51.7	3g4lA-5ohjA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3G4L_A_ROFA901_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	11 / 12	TYR A 405 HIS A 406 MET A 519 ASN A 567 PRO A 568 TYR A 575 TRP A 578 THR A 579 ILE A 582 SER A 614 PHE A 618	None None 9VE A 801 (-3.8A) 9VE A 801 (-4.1A) 9VE A 801 (-3.9A) 9VE A 801 (-4.6A) None 9VE A 801 (-4.1A) 9VE A 801 (-4.1A) 9VE A 801 (-4.7A) 9VE A 801 (-3.9A)	0.27A	3g4lA-5ohjA: 51.7	3g4lA-5ohjA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3G4L_B_ROFB902_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	11 / 12	TYR A 405 HIS A 406 MET A 519 ASP A 564 LEU A 565 PRO A 568 TRP A 578 THR A 579 ILE A 582 MET A 583 PHE A 618	None None 9VE A 801 (-3.8A) ZN A 699 ( 2.6A) 9VE A 801 (-4.7A) 9VE A 801 (-3.9A) None 9VE A 801 (-4.1A) 9VE A 801 (-4.1A) 9VE A 801 ( 4.0A) 9VE A 801 (-3.9A)	0.26A	3g4lB-5ohjA: 52.0	3g4lB-5ohjA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3G4L_B_ROFB902_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	11 / 12	TYR A 405 HIS A 406 MET A 519 LEU A 565 PRO A 568 TRP A 578 THR A 579 ILE A 582 MET A 583 MET A 603 PHE A 618	None None 9VE A 801 (-3.8A) 9VE A 801 (-4.7A) 9VE A 801 (-3.9A) None 9VE A 801 (-4.1A) 9VE A 801 (-4.1A) 9VE A 801 ( 4.0A) 9VE A 801 (-3.6A) 9VE A 801 (-3.9A)	0.52A	3g4lB-5ohjA: 52.0	3g4lB-5ohjA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3G4L_C_ROFC903_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	11 / 12	TYR A 405 HIS A 406 MET A 519 ASP A 564 LEU A 565 ASN A 567 PRO A 568 TYR A 575 TRP A 578 THR A 579 ILE A 582	None None 9VE A 801 (-3.8A) ZN A 699 ( 2.6A) 9VE A 801 (-4.7A) 9VE A 801 (-4.1A) 9VE A 801 (-3.9A) 9VE A 801 (-4.6A) None 9VE A 801 (-4.1A) 9VE A 801 (-4.1A)	0.26A	3g4lC-5ohjA: 52.1	3g4lC-5ohjA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3G4L_C_ROFC903_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	9 / 12	TYR A 405 LEU A 565 ASN A 567 PRO A 568 TYR A 575 TRP A 578 THR A 579 ILE A 582 MET A 603	None 9VE A 801 (-4.7A) 9VE A 801 (-4.1A) 9VE A 801 (-3.9A) 9VE A 801 (-4.6A) None 9VE A 801 (-4.1A) 9VE A 801 (-4.1A) 9VE A 801 (-3.6A)	0.55A	3g4lC-5ohjA: 52.1	3g4lC-5ohjA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3G4L_C_ROFC903_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	3 / 3	SER A 614 GLN A 615 PHE A 618	9VE A 801 (-4.7A) 9VE A 801 (-3.2A) 9VE A 801 (-3.9A)	0.18A	3g4lC-5ohjA: 52.1	3g4lC-5ohjA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3G4L_D_ROFD904_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	12 / 12	TYR A 405 HIS A 406 MET A 519 ASP A 564 LEU A 565 PRO A 568 TRP A 578 THR A 579 ILE A 582 MET A 583 SER A 614 GLN A 615	None None 9VE A 801 (-3.8A) ZN A 699 ( 2.6A) 9VE A 801 (-4.7A) 9VE A 801 (-3.9A) None 9VE A 801 (-4.1A) 9VE A 801 (-4.1A) 9VE A 801 ( 4.0A) 9VE A 801 (-4.7A) 9VE A 801 (-3.2A)	0.23A	3g4lD-5ohjA: 53.5	3g4lD-5ohjA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3G4L_D_ROFD904_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	3 / 3	ASN A 567 MET A 603 PHE A 618	9VE A 801 (-4.1A) 9VE A 801 (-3.6A) 9VE A 801 (-3.9A)	0.86A	3g4lD-5ohjA: 53.5	3g4lD-5ohjA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3IAK_A_EV1A415_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	7 / 9	MET A 519 ASN A 567 ILE A 582 PHE A 586 MET A 603 GLN A 615 PHE A 618	9VE A 801 (-3.8A) 9VE A 801 (-4.1A) 9VE A 801 (-4.1A) 9VE A 801 (-3.6A) 9VE A 801 (-3.6A) 9VE A 801 (-3.2A) 9VE A 801 (-3.9A)	0.92A	3iakA-5ohjA: 51.5	3iakA-5ohjA: 11.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3IAK_A_EV1A415_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	8 / 9	TYR A 405 ASN A 567 ILE A 582 PHE A 586 MET A 603 GLN A 615 PHE A 618 ILE A 622	None 9VE A 801 (-4.1A) 9VE A 801 (-4.1A) 9VE A 801 (-3.6A) 9VE A 801 (-3.6A) 9VE A 801 (-3.2A) 9VE A 801 (-3.9A) 9VE A 801 (-4.8A)	0.63A	3iakA-5ohjA: 51.5	3iakA-5ohjA: 11.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ID5_B_SAMB301_0 (FIBRILLARIN-LIKE RRNA/TRNA 2'-O-METHYLTRANSFERA SE)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	5 / 11	THR A 332 ASP A 413 ALA A 412 ILE A 367 GLN A 416	None	0.97A	3id5B-5ohjA: undetectable	3id5B-5ohjA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ID5_F_SAMF301_0 (FIBRILLARIN-LIKE RRNA/TRNA 2'-O-METHYLTRANSFERA SE)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	5 / 11	THR A 332 ASP A 413 ALA A 412 ILE A 367 GLN A 416	None	0.97A	3id5F-5ohjA: undetectable	3id5F-5ohjA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JWQ_A_VIAA901_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE CATALYTIC DOMAIN, CONE CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE SUBUNIT ALPHA CHIMERA)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	5 / 9	TYR A 405 HIS A 406 MET A 603 GLN A 615 PHE A 618	None None 9VE A 801 (-3.6A) 9VE A 801 (-3.2A) 9VE A 801 (-3.9A)	0.63A	3jwqA-5ohjA: 39.2	3jwqA-5ohjA: 13.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JWQ_B_VIAB901_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE CATALYTIC DOMAIN, CONE CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE SUBUNIT ALPHA CHIMERA)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	5 / 11	TYR A 405 HIS A 406 MET A 603 GLN A 615 PHE A 618	None None 9VE A 801 (-3.6A) 9VE A 801 (-3.2A) 9VE A 801 (-3.9A)	0.59A	3jwqB-5ohjA: 39.2 3jwqC-5ohjA: 39.1	3jwqB-5ohjA: 13.64 3jwqC-5ohjA: 13.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JWQ_C_VIAC901_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE CATALYTIC DOMAIN, CONE CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE SUBUNIT ALPHA CHIMERA)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	5 / 7	TYR A 405 HIS A 406 MET A 603 GLN A 615 PHE A 618	None None 9VE A 801 (-3.6A) 9VE A 801 (-3.2A) 9VE A 801 (-3.9A)	0.62A	3jwqC-5ohjA: 39.1	3jwqC-5ohjA: 13.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JWQ_D_VIAD901_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE CATALYTIC DOMAIN, CONE CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE SUBUNIT ALPHA CHIMERA)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	6 / 11	TYR A 405 HIS A 406 PHE A 586 MET A 603 GLN A 615 PHE A 618	None None 9VE A 801 (-3.6A) 9VE A 801 (-3.6A) 9VE A 801 (-3.2A) 9VE A 801 (-3.9A)	0.72A	3jwqA-5ohjA: 39.2 3jwqD-5ohjA: 39.0	3jwqA-5ohjA: 13.64 3jwqD-5ohjA: 13.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TVX_A_PNXA902_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4A)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	9 / 9	TYR A 405 LEU A 565 ASN A 567 PRO A 568 THR A 579 ILE A 582 MET A 603 GLN A 615 PHE A 618	None 9VE A 801 (-4.7A) 9VE A 801 (-4.1A) 9VE A 801 (-3.9A) 9VE A 801 (-4.1A) 9VE A 801 (-4.1A) 9VE A 801 (-3.6A) 9VE A 801 (-3.2A) 9VE A 801 (-3.9A)	0.60A	3tvxA-5ohjA: 54.7	3tvxA-5ohjA: 13.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TVX_B_PNXB902_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4A)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	7 / 7	TYR A 405 ASN A 567 ILE A 582 PHE A 586 MET A 603 GLN A 615 PHE A 618	None 9VE A 801 (-4.1A) 9VE A 801 (-4.1A) 9VE A 801 (-3.6A) 9VE A 801 (-3.6A) 9VE A 801 (-3.2A) 9VE A 801 (-3.9A)	0.58A	3tvxB-5ohjA: 54.4	3tvxB-5ohjA: 13.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WFH_B_P2EB301_1 (MAB FAB H FRAGMENT MAB FAB L FRAGMENT)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	5 / 12	HIS A 479 VAL A 482 HIS A 450 PRO A 451 LEU A 465	None	1.26A	3wfhA-5ohjA: undetectable 3wfhB-5ohjA: undetectable	3wfhA-5ohjA: 17.99 3wfhB-5ohjA: 15.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WHX_B_XPGB301_1 (MAB FAB H FRAGMENT MAB FAB L FRAGMENT)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	5 / 12	HIS A 479 VAL A 482 HIS A 450 PRO A 451 LEU A 465	None	1.25A	3whxA-5ohjA: undetectable 3whxB-5ohjA: undetectable	3whxA-5ohjA: 17.99 3whxB-5ohjA: 15.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4AX8_A_SAMA1474_1 (WBDD)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	4 / 6	TYR A 469 ASP A 449 GLU A 489 LEU A 480	None	1.35A	4ax8A-5ohjA: undetectable	4ax8A-5ohjA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4IAQ_A_2GMA2001_2 (CHIMERA PROTEIN OF HUMAN 5-HYDROXYTRYPTAMINE RECEPTOR 1B AND E. COLI SOLUBLE CYTOCHROME B562)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	4 / 6	ILE A 582 THR A 579 VAL A 453 ASP A 402	9VE A 801 (-4.1A) 9VE A 801 (-4.1A) None None	1.05A	4iaqA-5ohjA: undetectable	4iaqA-5ohjA: 11.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4JBT_B_ASDB502_1 (CYTOCHROME P450 MONOOXYGENASE)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	5 / 11	PHE A 372 ALA A 438 ALA A 439 THR A 418 VAL A 414	None	1.15A	4jbtB-5ohjA: undetectable	4jbtB-5ohjA: 9.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XI3_D_29SD601_1 (ESTROGEN RECEPTOR)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	5 / 12	ALA A 563 TRP A 348 LEU A 421 LEU A 422 MET A 368	None	1.08A	4xi3D-5ohjA: undetectable	4xi3D-5ohjA: 17.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFIC LECTIN)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	5 / 8	GLU A 585 VAL A 403 HIS A 406 ASP A 447 HIS A 479	None None None MG A 700 ( 2.7A) None	1.19A	5f8yA-5ohjA: undetectable	5f8yA-5ohjA: 20.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFIC LECTIN)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	5 / 8	GLU A 585 VAL A 403 HIS A 406 ASP A 447 HIS A 479	None None None MG A 700 ( 2.7A) None	1.21A	5f8yB-5ohjA: undetectable	5f8yB-5ohjA: 20.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5G6S_A_RAUA400_1 (IMINE REDUCTASE)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	5 / 11	LEU A 395 MET A 392 PHE A 388 MET A 368 GLY A 483	None	1.24A	5g6sA-5ohjA: undetectable 5g6sG-5ohjA: undetectable	5g6sA-5ohjA: 12.54 5g6sG-5ohjA: 12.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5G6S_A_RAUA400_1 (IMINE REDUCTASE)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	5 / 11	LEU A 395 MET A 392 TYR A 391 MET A 368 GLY A 483	None	0.93A	5g6sA-5ohjA: undetectable 5g6sG-5ohjA: undetectable	5g6sA-5ohjA: 12.54 5g6sG-5ohjA: 12.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5G6S_B_RAUB400_1 (IMINE REDUCTASE)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	5 / 11	LEU A 395 MET A 392 TYR A 391 MET A 368 GLY A 483	None	0.94A	5g6sB-5ohjA: undetectable 5g6sC-5ohjA: undetectable	5g6sB-5ohjA: 12.54 5g6sC-5ohjA: 12.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5G6S_C_RAUC400_1 (IMINE REDUCTASE)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	5 / 12	MET A 368 GLY A 483 LEU A 395 MET A 392 PHE A 388	None	1.24A	5g6sB-5ohjA: undetectable 5g6sC-5ohjA: undetectable	5g6sB-5ohjA: 12.54 5g6sC-5ohjA: 12.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5G6S_C_RAUC400_1 (IMINE REDUCTASE)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	5 / 12	MET A 368 GLY A 483 LEU A 395 MET A 392 TYR A 391	None	0.94A	5g6sB-5ohjA: undetectable 5g6sC-5ohjA: undetectable	5g6sB-5ohjA: 12.54 5g6sC-5ohjA: 12.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5G6S_D_RAUD400_1 (IMINE REDUCTASE)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	5 / 10	LEU A 395 MET A 392 PHE A 388 MET A 368 GLY A 483	None	1.24A	5g6sD-5ohjA: undetectable 5g6sF-5ohjA: undetectable	5g6sD-5ohjA: 12.54 5g6sF-5ohjA: 12.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5G6S_D_RAUD400_1 (IMINE REDUCTASE)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	5 / 10	LEU A 395 MET A 392 TYR A 391 MET A 368 GLY A 483	None	0.94A	5g6sD-5ohjA: undetectable 5g6sF-5ohjA: undetectable	5g6sD-5ohjA: 12.54 5g6sF-5ohjA: 12.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5G6S_E_RAUE400_1 (IMINE REDUCTASE)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	5 / 11	LEU A 395 MET A 392 PHE A 388 MET A 368 GLY A 483	None	1.25A	5g6sE-5ohjA: undetectable 5g6sH-5ohjA: undetectable	5g6sE-5ohjA: 12.54 5g6sH-5ohjA: 12.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5G6S_E_RAUE400_1 (IMINE REDUCTASE)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	5 / 11	LEU A 395 MET A 392 TYR A 391 MET A 368 GLY A 483	None	0.94A	5g6sE-5ohjA: undetectable 5g6sH-5ohjA: undetectable	5g6sE-5ohjA: 12.54 5g6sH-5ohjA: 12.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5GTR_A_ESTA601_1 (ESTROGEN RECEPTOR)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	5 / 12	ALA A 563 LEU A 421 LEU A 422 MET A 368 ILE A 371	None	1.07A	5gtrA-5ohjA: 3.2	5gtrA-5ohjA: 17.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5XDH_A_DAHA60_1 (PUTATIVE CYTOCHROME C)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	4 / 6	HIS A 400 VAL A 453 LEU A 475 GLN A 589	None None None 9VE A 801 (-3.4A)	1.41A	5xdhA-5ohjA: undetectable 5xdhC-5ohjA: 0.0	5xdhA-5ohjA: 18.48 5xdhC-5ohjA: 18.48

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1G5Y_B_9CRB501_1","RETINOIC ACID RECEPTOR RXR-ALPHA","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",5,"ILE A 367;ALA A 415;LEU A 422;LEU A 377;ILE A 371","None","1.24A","1g5yB-5ohjA:undetectable","1g5yB-5ohjA:19.46"],["1GSE_A_EAAA224_1","GLUTATHIONE TRANSFERASE","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",5,"ARG A 375;LEU A 437;LEU A 506;VAL A 510;ALA A 444","None","1.04A","1gseA-5ohjA:undetectable","1gseA-5ohjA:15.53"],["1QKU_A_ESTA600_1","ESTRADIOL RECEPTOR","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",5,"ALA A 563;LEU A 421;LEU A 422;MET A 368;ILE A 371","None","1.08A","1qkuA-5ohjA:undetectable","1qkuA-5ohjA:17.20"],["1QKU_B_ESTB600_1","ESTRADIOL RECEPTOR","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",5,"ALA A 563;LEU A 421;LEU A 422;MET A 368;ILE A 371","None","1.07A","1qkuB-5ohjA:1.9","1qkuB-5ohjA:17.20"],["1QKU_C_ESTC600_1","ESTRADIOL RECEPTOR","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",5,"ALA A 563;LEU A 421;LEU A 422;MET A 368;ILE A 371","None","1.08A","1qkuC-5ohjA:1.9","1qkuC-5ohjA:17.20"],["1UHO_A_VDNA1000_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",6,"TYR A 405;HIS A 406;PHE A 586;GLN A 615;GLY A 617;PHE A 618","None;None;9VE A 801 (-3.6A);9VE A 801 (-3.2A);None;9VE A 801 (-3.9A)","0.34A","1uhoA-5ohjA:36.4","1uhoA-5ohjA:12.96"],["1XLX_A_CIOA101_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",5,"HIS A 446;MET A 519;THR A 579;GLN A 615;PHE A 618"," ZN A 699 (-3.2A);9VE A 801 (-3.8A);9VE A 801 (-4.1A);9VE A 801 (-3.2A);9VE A 801 (-3.9A)","1.43A","1xlxA-5ohjA:52.6","1xlxA-5ohjA:11.31"],["1XLX_A_CIOA101_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",12,"TYR A 405;HIS A 406;HIS A 450;MET A 519;LEU A 565;ASN A 567;THR A 579;ILE A 582;MET A 583;SER A 614;GLN A 615;PHE A 618","None;None;None;9VE A 801 (-3.8A);9VE A 801 (-4.7A);9VE A 801 (-4.1A);9VE A 801 (-4.1A);9VE A 801 (-4.1A);9VE A 801 ( 4.0A);9VE A 801 (-4.7A);9VE A 801 (-3.2A);9VE A 801 (-3.9A)","0.36A","1xlxA-5ohjA:52.6","1xlxA-5ohjA:11.31"],["1XLX_B_CIOB102_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",8,"HIS A 406;HIS A 450;MET A 519;MET A 583;PHE A 586;MET A 603;SER A 614;PHE A 618","None;None;9VE A 801 (-3.8A);9VE A 801 ( 4.0A);9VE A 801 (-3.6A);9VE A 801 (-3.6A);9VE A 801 (-4.7A);9VE A 801 (-3.9A)","0.94A","1xlxB-5ohjA:52.6","1xlxB-5ohjA:11.31"],["1XLX_B_CIOB102_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",5,"HIS A 446;MET A 519;THR A 579;GLN A 615;PHE A 618"," ZN A 699 (-3.2A);9VE A 801 (-3.8A);9VE A 801 (-4.1A);9VE A 801 (-3.2A);9VE A 801 (-3.9A)","1.44A","1xlxB-5ohjA:52.6","1xlxB-5ohjA:11.31"],["1XLX_B_CIOB102_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",11,"TYR A 405;HIS A 406;HIS A 450;MET A 519;THR A 579;ILE A 582;MET A 583;PHE A 586;MET A 603;GLN A 615;PHE A 618","None;None;None;9VE A 801 (-3.8A);9VE A 801 (-4.1A);9VE A 801 (-4.1A);9VE A 801 ( 4.0A);9VE A 801 (-3.6A);9VE A 801 (-3.6A);9VE A 801 (-3.2A);9VE A 801 (-3.9A)","0.62A","1xlxB-5ohjA:52.6","1xlxB-5ohjA:11.31"],["1XMU_A_ROFA101_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",11,"TYR A 405;HIS A 406;ASP A 564;LEU A 565;PRO A 568;TYR A 575;TRP A 578;ILE A 582;PHE A 586;SER A 614;PHE A 618","None;None; ZN A 699 ( 2.6A);9VE A 801 (-4.7A);9VE A 801 (-3.9A);9VE A 801 (-4.6A);None;9VE A 801 (-4.1A);9VE A 801 (-3.6A);9VE A 801 (-4.7A);9VE A 801 (-3.9A)","0.26A","1xmuA-5ohjA:53.3","1xmuA-5ohjA:undetectable"],["1XMU_A_ROFA101_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",8,"TYR A 405;LEU A 565;PRO A 568;TYR A 575;TRP A 578;ILE A 582;MET A 603;PHE A 618","None;9VE A 801 (-4.7A);9VE A 801 (-3.9A);9VE A 801 (-4.6A);None;9VE A 801 (-4.1A);9VE A 801 (-3.6A);9VE A 801 (-3.9A)","0.67A","1xmuA-5ohjA:53.3","1xmuA-5ohjA:undetectable"],["1XMU_A_ROFA101_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",5,"MET A 519;ASN A 567;THR A 579;MET A 583;GLN A 615","9VE A 801 (-3.8A);9VE A 801 (-4.1A);9VE A 801 (-4.1A);9VE A 801 ( 4.0A);9VE A 801 (-3.2A)","0.28A","1xmuA-5ohjA:53.3","1xmuA-5ohjA:undetectable"],["1XMU_B_ROFB102_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",11,"TYR A 405;HIS A 406;MET A 519;ASP A 564;LEU A 565;PRO A 568;TYR A 575;TRP A 578;ILE A 582;PHE A 586;SER A 614","None;None;9VE A 801 (-3.8A); ZN A 699 ( 2.6A);9VE A 801 (-4.7A);9VE A 801 (-3.9A);9VE A 801 (-4.6A);None;9VE A 801 (-4.1A);9VE A 801 (-3.6A);9VE A 801 (-4.7A)","0.30A","1xmuB-5ohjA:52.8","1xmuB-5ohjA:undetectable"],["1XMU_B_ROFB102_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",10,"TYR A 405;MET A 519;ASP A 564;LEU A 565;PRO A 568;TYR A 575;TRP A 578;ILE A 582;MET A 603;SER A 614","None;9VE A 801 (-3.8A); ZN A 699 ( 2.6A);9VE A 801 (-4.7A);9VE A 801 (-3.9A);9VE A 801 (-4.6A);None;9VE A 801 (-4.1A);9VE A 801 (-3.6A);9VE A 801 (-4.7A)","0.65A","1xmuB-5ohjA:52.8","1xmuB-5ohjA:undetectable"],["1XMU_B_ROFB102_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",5,"ASN A 567;THR A 579;MET A 583;GLN A 615;PHE A 618","9VE A 801 (-4.1A);9VE A 801 (-4.1A);9VE A 801 ( 4.0A);9VE A 801 (-3.2A);9VE A 801 (-3.9A)","0.15A","1xmuB-5ohjA:52.8","1xmuB-5ohjA:undetectable"],["1XOM_A_CIOA603_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",6,"TYR A 405;ASP A 447;ILE A 582;MET A 583;PHE A 586;MET A 603","None; MG A 700 ( 2.7A);9VE A 801 (-4.1A);9VE A 801 ( 4.0A);9VE A 801 (-3.6A);9VE A 801 (-3.6A)","1.41A","1xomA-5ohjA:52.6","1xomA-5ohjA:11.75"],["1XOM_A_CIOA603_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",11,"TYR A 405;HIS A 406;MET A 519;ASP A 564;LEU A 565;ILE A 582;MET A 583;PHE A 586;MET A 603;GLN A 615;PHE A 618","None;None;9VE A 801 (-3.8A); ZN A 699 ( 2.6A);9VE A 801 (-4.7A);9VE A 801 (-4.1A);9VE A 801 ( 4.0A);9VE A 801 (-3.6A);9VE A 801 (-3.6A);9VE A 801 (-3.2A);9VE A 801 (-3.9A)","0.59A","1xomA-5ohjA:52.6","1xomA-5ohjA:11.75"],["1XOM_A_CIOA603_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",11,"TYR A 405;HIS A 406;MET A 519;ASP A 564;LEU A 565;ILE A 582;MET A 583;PHE A 586;SER A 614;GLN A 615;PHE A 618","None;None;9VE A 801 (-3.8A); ZN A 699 ( 2.6A);9VE A 801 (-4.7A);9VE A 801 (-4.1A);9VE A 801 ( 4.0A);9VE A 801 (-3.6A);9VE A 801 (-4.7A);9VE A 801 (-3.2A);9VE A 801 (-3.9A)","0.27A","1xomA-5ohjA:52.6","1xomA-5ohjA:11.75"],["1XOM_B_CIOB601_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",11,"TYR A 405;HIS A 406;MET A 519;LEU A 565;THR A 579;ILE A 582;MET A 583;PHE A 586;MET A 603;GLN A 615;PHE A 618","None;None;9VE A 801 (-3.8A);9VE A 801 (-4.7A);9VE A 801 (-4.1A);9VE A 801 (-4.1A);9VE A 801 ( 4.0A);9VE A 801 (-3.6A);9VE A 801 (-3.6A);9VE A 801 (-3.2A);9VE A 801 (-3.9A)","0.58A","1xomB-5ohjA:52.1","1xomB-5ohjA:11.75"],["1XOM_B_CIOB601_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",11,"TYR A 405;HIS A 406;MET A 519;LEU A 565;THR A 579;ILE A 582;MET A 583;PHE A 586;SER A 614;GLN A 615;PHE A 618","None;None;9VE A 801 (-3.8A);9VE A 801 (-4.7A);9VE A 801 (-4.1A);9VE A 801 (-4.1A);9VE A 801 ( 4.0A);9VE A 801 (-3.6A);9VE A 801 (-4.7A);9VE A 801 (-3.2A);9VE A 801 (-3.9A)","0.29A","1xomB-5ohjA:52.1","1xomB-5ohjA:11.75"],["1XOM_B_CIOB601_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",7,"TYR A 405;HIS A 410;MET A 519;LEU A 565;THR A 579;GLN A 615;PHE A 618","None; ZN A 699 (-3.3A);9VE A 801 (-3.8A);9VE A 801 (-4.7A);9VE A 801 (-4.1A);9VE A 801 (-3.2A);9VE A 801 (-3.9A)","1.47A","1xomB-5ohjA:52.1","1xomB-5ohjA:11.75"],["1XOQ_A_ROFA502_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",11,"TYR A 405;HIS A 406;MET A 519;ASP A 564;LEU A 565;PRO A 568;TYR A 575;THR A 579;ILE A 582;SER A 614;PHE A 618","None;None;9VE A 801 (-3.8A); ZN A 699 ( 2.6A);9VE A 801 (-4.7A);9VE A 801 (-3.9A);9VE A 801 (-4.6A);9VE A 801 (-4.1A);9VE A 801 (-4.1A);9VE A 801 (-4.7A);9VE A 801 (-3.9A)","0.25A","1xoqA-5ohjA:52.6","1xoqA-5ohjA:undetectable"],["1XOQ_A_ROFA502_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",9,"TYR A 405;LEU A 565;PRO A 568;TYR A 575;THR A 579;ILE A 582;MET A 603;SER A 614;PHE A 618","None;9VE A 801 (-4.7A);9VE A 801 (-3.9A);9VE A 801 (-4.6A);9VE A 801 (-4.1A);9VE A 801 (-4.1A);9VE A 801 (-3.6A);9VE A 801 (-4.7A);9VE A 801 (-3.9A)","0.56A","1xoqA-5ohjA:52.6","1xoqA-5ohjA:undetectable"],["1XOQ_A_ROFA502_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",3,"ASN A 567;TRP A 578;GLN A 615","9VE A 801 (-4.1A);None;9VE A 801 (-3.2A)","0.10A","1xoqA-5ohjA:52.6","1xoqA-5ohjA:undetectable"],["1XOQ_B_ROFB501_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",11,"TYR A 405;HIS A 406;ASP A 564;LEU A 565;PRO A 568;TYR A 575;TRP A 578;THR A 579;ILE A 582;SER A 614;PHE A 618","None;None; ZN A 699 ( 2.6A);9VE A 801 (-4.7A);9VE A 801 (-3.9A);9VE A 801 (-4.6A);None;9VE A 801 (-4.1A);9VE A 801 (-4.1A);9VE A 801 (-4.7A);9VE A 801 (-3.9A)","0.15A","1xoqB-5ohjA:51.9","1xoqB-5ohjA:undetectable"],["1XOQ_B_ROFB501_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",9,"TYR A 405;LEU A 565;PRO A 568;TYR A 575;TRP A 578;THR A 579;ILE A 582;MET A 603;PHE A 618","None;9VE A 801 (-4.7A);9VE A 801 (-3.9A);9VE A 801 (-4.6A);None;9VE A 801 (-4.1A);9VE A 801 (-4.1A);9VE A 801 (-3.6A);9VE A 801 (-3.9A)","0.55A","1xoqB-5ohjA:51.9","1xoqB-5ohjA:undetectable"],["1XOQ_B_ROFB501_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",3,"MET A 519;ASN A 567;GLN A 615","9VE A 801 (-3.8A);9VE A 801 (-4.1A);9VE A 801 (-3.2A)","0.31A","1xoqB-5ohjA:51.9","1xoqB-5ohjA:undetectable"],["1XOS_A_VIAA1_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",11,"TYR A 405;HIS A 406;MET A 519;ASP A 564;LEU A 565;MET A 583;PHE A 586;MET A 603;GLN A 615;PHE A 618;ILE A 622","None;None;9VE A 801 (-3.8A); ZN A 699 ( 2.6A);9VE A 801 (-4.7A);9VE A 801 ( 4.0A);9VE A 801 (-3.6A);9VE A 801 (-3.6A);9VE A 801 (-3.2A);9VE A 801 (-3.9A);9VE A 801 (-4.8A)","0.61A","1xosA-5ohjA:52.1","1xosA-5ohjA:11.31"],["1XOS_A_VIAA1_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",7,"TYR A 405;HIS A 406;MET A 519;ASP A 564;MET A 583;PHE A 586;SER A 601","None;None;9VE A 801 (-3.8A); ZN A 699 ( 2.6A);9VE A 801 ( 4.0A);9VE A 801 (-3.6A);None","1.21A","1xosA-5ohjA:52.1","1xosA-5ohjA:11.31"],["1XOS_A_VIAA1_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",7,"TYR A 405;HIS A 410;MET A 519;LEU A 565;GLN A 615;PHE A 618;ILE A 622","None; ZN A 699 (-3.3A);9VE A 801 (-3.8A);9VE A 801 (-4.7A);9VE A 801 (-3.2A);9VE A 801 (-3.9A);9VE A 801 (-4.8A)","1.46A","1xosA-5ohjA:52.1","1xosA-5ohjA:11.31"],["1XOT_A_VDNA101_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",12,"TYR A 405;HIS A 406;MET A 519;LEU A 565;ILE A 582;MET A 583;SER A 601;MET A 603;SER A 614;GLN A 615;PHE A 618;ILE A 622","None;None;9VE A 801 (-3.8A);9VE A 801 (-4.7A);9VE A 801 (-4.1A);9VE A 801 ( 4.0A);None;9VE A 801 (-3.6A);9VE A 801 (-4.7A);9VE A 801 (-3.2A);9VE A 801 (-3.9A);9VE A 801 (-4.8A)","0.92A","1xotA-5ohjA:52.6","1xotA-5ohjA:11.31"],["1XOT_B_VDNB102_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",8,"HIS A 406;MET A 519;LEU A 565;MET A 583;SER A 601;MET A 603;SER A 614;PHE A 618","None;9VE A 801 (-3.8A);9VE A 801 (-4.7A);9VE A 801 ( 4.0A);None;9VE A 801 (-3.6A);9VE A 801 (-4.7A);9VE A 801 (-3.9A)","0.91A","1xotB-5ohjA:52.6","1xotB-5ohjA:11.31"],["1XOT_B_VDNB102_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",11,"TYR A 405;HIS A 406;MET A 519;LEU A 565;ASN A 567;ILE A 582;MET A 583;SER A 601;MET A 603;GLN A 615;PHE A 618","None;None;9VE A 801 (-3.8A);9VE A 801 (-4.7A);9VE A 801 (-4.1A);9VE A 801 (-4.1A);9VE A 801 ( 4.0A);None;9VE A 801 (-3.6A);9VE A 801 (-3.2A);9VE A 801 (-3.9A)","0.64A","1xotB-5ohjA:52.6","1xotB-5ohjA:11.31"],["2H42_A_VIAA901_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",5,"TYR A 405;HIS A 406;PHE A 586;GLN A 615;PHE A 618","None;None;9VE A 801 (-3.6A);9VE A 801 (-3.2A);9VE A 801 (-3.9A)","0.37A","2h42A-5ohjA:36.2","2h42A-5ohjA:13.19"],["2H42_C_VIAC903_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",5,"TYR A 405;LEU A 565;PHE A 586;GLN A 615;PHE A 618","None;9VE A 801 (-4.7A);9VE A 801 (-3.6A);9VE A 801 (-3.2A);9VE A 801 (-3.9A)","0.56A","2h42C-5ohjA:35.9","2h42C-5ohjA:13.19"],["2JFA_A_RALA600_1","ESTROGEN RECEPTOR","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",5,"ALA A 563;TRP A 348;LEU A 421;LEU A 422;MET A 368","None","1.10A","2jfaA-5ohjA:2.1","2jfaA-5ohjA:15.48"],["2JFA_B_RALB600_1","ESTROGEN RECEPTOR","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",5,"ALA A 563;TRP A 348;LEU A 421;LEU A 422;MET A 368","None","1.12A","2jfaB-5ohjA:2.0","2jfaB-5ohjA:15.48"],["2WEY_A_EV1A1771_1","CAMP AND CAMP-INHIBITED CGMP 3', 5'-CYCLIC PHOSPHODIESTERASE","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",9,"TYR A 405;HIS A 406;LEU A 565;ILE A 582;GLU A 585;PHE A 586;MET A 603;GLN A 615;PHE A 618","None;None;9VE A 801 (-4.7A);9VE A 801 (-4.1A);None;9VE A 801 (-3.6A);9VE A 801 (-3.6A);9VE A 801 (-3.2A);9VE A 801 (-3.9A)","1.04A","2weyA-5ohjA:37.9","2weyA-5ohjA:11.47"],["2YJA_B_ESTB1550_1","ESTROGEN RECEPTOR","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",5,"ALA A 563;LEU A 421;LEU A 422;MET A 368;ILE A 371","None","1.12A","2yjaB-5ohjA:3.0","2yjaB-5ohjA:16.86"],["3ARR_A_PNXA607_1","CHITINASE A","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",4,"VAL A 414;SER A 566;THR A 418;LEU A 421","None","1.21A","3arrA-5ohjA:undetectable","3arrA-5ohjA:10.20"],["3B2R_A_VDNA1_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",6,"TYR A 405;HIS A 406;LEU A 565;PHE A 586;GLN A 615;PHE A 618","None;None;9VE A 801 (-4.7A);9VE A 801 (-3.6A);9VE A 801 (-3.2A);9VE A 801 (-3.9A)","0.68A","3b2rA-5ohjA:31.5","3b2rA-5ohjA:13.64"],["3B2R_B_VDNB1_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",5,"TYR A 405;HIS A 406;LEU A 565;GLN A 615;PHE A 618","None;None;9VE A 801 (-4.7A);9VE A 801 (-3.2A);9VE A 801 (-3.9A)","0.69A","3b2rB-5ohjA:31.5","3b2rB-5ohjA:13.64"],["3CZV_A_AZMA263_1","CARBONIC ANHYDRASE 13;CARBONIC ANHYDRASE 13","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",5,"HIS A 410;HIS A 446;PHE A 618;THR A 517;VAL A 623"," ZN A 699 (-3.3A); ZN A 699 (-3.2A);9VE A 801 (-3.9A);None;None","1.11A","3czvA-5ohjA:undetectable;3czvB-5ohjA:undetectable","3czvA-5ohjA:14.92;3czvB-5ohjA:14.92"],["3G4L_A_ROFA901_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",9,"TYR A 405;ASN A 567;PRO A 568;TYR A 575;TRP A 578;THR A 579;ILE A 582;MET A 603;PHE A 618","None;9VE A 801 (-4.1A);9VE A 801 (-3.9A);9VE A 801 (-4.6A);None;9VE A 801 (-4.1A);9VE A 801 (-4.1A);9VE A 801 (-3.6A);9VE A 801 (-3.9A)","0.68A","3g4lA-5ohjA:51.7","3g4lA-5ohjA:undetectable"],["3G4L_A_ROFA901_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",11,"TYR A 405;HIS A 406;MET A 519;ASN A 567;PRO A 568;TYR A 575;TRP A 578;THR A 579;ILE A 582;SER A 614;PHE A 618","None;None;9VE A 801 (-3.8A);9VE A 801 (-4.1A);9VE A 801 (-3.9A);9VE A 801 (-4.6A);None;9VE A 801 (-4.1A);9VE A 801 (-4.1A);9VE A 801 (-4.7A);9VE A 801 (-3.9A)","0.27A","3g4lA-5ohjA:51.7","3g4lA-5ohjA:undetectable"],["3G4L_B_ROFB902_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",11,"TYR A 405;HIS A 406;MET A 519;ASP A 564;LEU A 565;PRO A 568;TRP A 578;THR A 579;ILE A 582;MET A 583;PHE A 618","None;None;9VE A 801 (-3.8A); ZN A 699 ( 2.6A);9VE A 801 (-4.7A);9VE A 801 (-3.9A);None;9VE A 801 (-4.1A);9VE A 801 (-4.1A);9VE A 801 ( 4.0A);9VE A 801 (-3.9A)","0.26A","3g4lB-5ohjA:52.0","3g4lB-5ohjA:undetectable"],["3G4L_B_ROFB902_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",11,"TYR A 405;HIS A 406;MET A 519;LEU A 565;PRO A 568;TRP A 578;THR A 579;ILE A 582;MET A 583;MET A 603;PHE A 618","None;None;9VE A 801 (-3.8A);9VE A 801 (-4.7A);9VE A 801 (-3.9A);None;9VE A 801 (-4.1A);9VE A 801 (-4.1A);9VE A 801 ( 4.0A);9VE A 801 (-3.6A);9VE A 801 (-3.9A)","0.52A","3g4lB-5ohjA:52.0","3g4lB-5ohjA:undetectable"],["3G4L_C_ROFC903_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",11,"TYR A 405;HIS A 406;MET A 519;ASP A 564;LEU A 565;ASN A 567;PRO A 568;TYR A 575;TRP A 578;THR A 579;ILE A 582","None;None;9VE A 801 (-3.8A); ZN A 699 ( 2.6A);9VE A 801 (-4.7A);9VE A 801 (-4.1A);9VE A 801 (-3.9A);9VE A 801 (-4.6A);None;9VE A 801 (-4.1A);9VE A 801 (-4.1A)","0.26A","3g4lC-5ohjA:52.1","3g4lC-5ohjA:undetectable"],["3G4L_C_ROFC903_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",9,"TYR A 405;LEU A 565;ASN A 567;PRO A 568;TYR A 575;TRP A 578;THR A 579;ILE A 582;MET A 603","None;9VE A 801 (-4.7A);9VE A 801 (-4.1A);9VE A 801 (-3.9A);9VE A 801 (-4.6A);None;9VE A 801 (-4.1A);9VE A 801 (-4.1A);9VE A 801 (-3.6A)","0.55A","3g4lC-5ohjA:52.1","3g4lC-5ohjA:undetectable"],["3G4L_C_ROFC903_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",3,"SER A 614;GLN A 615;PHE A 618","9VE A 801 (-4.7A);9VE A 801 (-3.2A);9VE A 801 (-3.9A)","0.18A","3g4lC-5ohjA:52.1","3g4lC-5ohjA:undetectable"],["3G4L_D_ROFD904_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",12,"TYR A 405;HIS A 406;MET A 519;ASP A 564;LEU A 565;PRO A 568;TRP A 578;THR A 579;ILE A 582;MET A 583;SER A 614;GLN A 615","None;None;9VE A 801 (-3.8A); ZN A 699 ( 2.6A);9VE A 801 (-4.7A);9VE A 801 (-3.9A);None;9VE A 801 (-4.1A);9VE A 801 (-4.1A);9VE A 801 ( 4.0A);9VE A 801 (-4.7A);9VE A 801 (-3.2A)","0.23A","3g4lD-5ohjA:53.5","3g4lD-5ohjA:undetectable"],["3G4L_D_ROFD904_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",3,"ASN A 567;MET A 603;PHE A 618","9VE A 801 (-4.1A);9VE A 801 (-3.6A);9VE A 801 (-3.9A)","0.86A","3g4lD-5ohjA:53.5","3g4lD-5ohjA:undetectable"],["3IAK_A_EV1A415_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",7,"MET A 519;ASN A 567;ILE A 582;PHE A 586;MET A 603;GLN A 615;PHE A 618","9VE A 801 (-3.8A);9VE A 801 (-4.1A);9VE A 801 (-4.1A);9VE A 801 (-3.6A);9VE A 801 (-3.6A);9VE A 801 (-3.2A);9VE A 801 (-3.9A)","0.92A","3iakA-5ohjA:51.5","3iakA-5ohjA:11.75"],["3IAK_A_EV1A415_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",8,"TYR A 405;ASN A 567;ILE A 582;PHE A 586;MET A 603;GLN A 615;PHE A 618;ILE A 622","None;9VE A 801 (-4.1A);9VE A 801 (-4.1A);9VE A 801 (-3.6A);9VE A 801 (-3.6A);9VE A 801 (-3.2A);9VE A 801 (-3.9A);9VE A 801 (-4.8A)","0.63A","3iakA-5ohjA:51.5","3iakA-5ohjA:11.75"],["3ID5_B_SAMB301_0","FIBRILLARIN-LIKE RRNA\/TRNA 2'-O-METHYLTRANSFERASE","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",5,"THR A 332;ASP A 413;ALA A 412;ILE A 367;GLN A 416","None","0.97A","3id5B-5ohjA:undetectable","3id5B-5ohjA:undetectable"],["3ID5_F_SAMF301_0","FIBRILLARIN-LIKE RRNA\/TRNA 2'-O-METHYLTRANSFERASE","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",5,"THR A 332;ASP A 413;ALA A 412;ILE A 367;GLN A 416","None","0.97A","3id5F-5ohjA:undetectable","3id5F-5ohjA:undetectable"],["3JWQ_A_VIAA901_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE CATALYTIC DOMAIN, CONE CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE SUBUNIT ALPHA CHIMERA","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",5,"TYR A 405;HIS A 406;MET A 603;GLN A 615;PHE A 618","None;None;9VE A 801 (-3.6A);9VE A 801 (-3.2A);9VE A 801 (-3.9A)","0.63A","3jwqA-5ohjA:39.2","3jwqA-5ohjA:13.64"],["3JWQ_B_VIAB901_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE CATALYTIC DOMAIN, CONE CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE SUBUNIT ALPHA CHIMERA;CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE CATALYTIC DOMAIN, CONE CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE SUBUNIT ALPHA CHIMERA","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",5,"TYR A 405;HIS A 406;MET A 603;GLN A 615;PHE A 618","None;None;9VE A 801 (-3.6A);9VE A 801 (-3.2A);9VE A 801 (-3.9A)","0.59A","3jwqB-5ohjA:39.2;3jwqC-5ohjA:39.1","3jwqB-5ohjA:13.64;3jwqC-5ohjA:13.64"],["3JWQ_C_VIAC901_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE CATALYTIC DOMAIN, CONE CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE SUBUNIT ALPHA CHIMERA","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",5,"TYR A 405;HIS A 406;MET A 603;GLN A 615;PHE A 618","None;None;9VE A 801 (-3.6A);9VE A 801 (-3.2A);9VE A 801 (-3.9A)","0.62A","3jwqC-5ohjA:39.1","3jwqC-5ohjA:13.64"],["3JWQ_D_VIAD901_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE CATALYTIC DOMAIN, CONE CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE SUBUNIT ALPHA CHIMERA;CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE CATALYTIC DOMAIN, CONE CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE SUBUNIT ALPHA CHIMERA","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",6,"TYR A 405;HIS A 406;PHE A 586;MET A 603;GLN A 615;PHE A 618","None;None;9VE A 801 (-3.6A);9VE A 801 (-3.6A);9VE A 801 (-3.2A);9VE A 801 (-3.9A)","0.72A","3jwqA-5ohjA:39.2;3jwqD-5ohjA:39.0","3jwqA-5ohjA:13.64;3jwqD-5ohjA:13.64"],["3TVX_A_PNXA902_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4A","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",9,"TYR A 405;LEU A 565;ASN A 567;PRO A 568;THR A 579;ILE A 582;MET A 603;GLN A 615;PHE A 618","None;9VE A 801 (-4.7A);9VE A 801 (-4.1A);9VE A 801 (-3.9A);9VE A 801 (-4.1A);9VE A 801 (-4.1A);9VE A 801 (-3.6A);9VE A 801 (-3.2A);9VE A 801 (-3.9A)","0.60A","3tvxA-5ohjA:54.7","3tvxA-5ohjA:13.25"],["3TVX_B_PNXB902_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4A","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",7,"TYR A 405;ASN A 567;ILE A 582;PHE A 586;MET A 603;GLN A 615;PHE A 618","None;9VE A 801 (-4.1A);9VE A 801 (-4.1A);9VE A 801 (-3.6A);9VE A 801 (-3.6A);9VE A 801 (-3.2A);9VE A 801 (-3.9A)","0.58A","3tvxB-5ohjA:54.4","3tvxB-5ohjA:13.25"],["3WFH_B_P2EB301_1","MAB FAB H FRAGMENT;MAB FAB L FRAGMENT","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",5,"HIS A 479;VAL A 482;HIS A 450;PRO A 451;LEU A 465","None","1.26A","3wfhA-5ohjA:undetectable;3wfhB-5ohjA:undetectable","3wfhA-5ohjA:17.99;3wfhB-5ohjA:15.27"],["3WHX_B_XPGB301_1","MAB FAB H FRAGMENT;MAB FAB L FRAGMENT","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",5,"HIS A 479;VAL A 482;HIS A 450;PRO A 451;LEU A 465","None","1.25A","3whxA-5ohjA:undetectable;3whxB-5ohjA:undetectable","3whxA-5ohjA:17.99;3whxB-5ohjA:15.27"],["4AX8_A_SAMA1474_1","WBDD","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",4,"TYR A 469;ASP A 449;GLU A 489;LEU A 480","None","1.35A","4ax8A-5ohjA:undetectable","4ax8A-5ohjA:undetectable"],["4IAQ_A_2GMA2001_2","CHIMERA PROTEIN OF HUMAN 5-HYDROXYTRYPTAMINE RECEPTOR 1B AND E. COLI SOLUBLE CYTOCHROME B562","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",4,"ILE A 582;THR A 579;VAL A 453;ASP A 402","9VE A 801 (-4.1A);9VE A 801 (-4.1A);None;None","1.05A","4iaqA-5ohjA:undetectable","4iaqA-5ohjA:11.66"],["4JBT_B_ASDB502_1","CYTOCHROME P450 MONOOXYGENASE","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",5,"PHE A 372;ALA A 438;ALA A 439;THR A 418;VAL A 414","None","1.15A","4jbtB-5ohjA:undetectable","4jbtB-5ohjA:9.95"],["4XI3_D_29SD601_1","ESTROGEN RECEPTOR","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",5,"ALA A 563;TRP A 348;LEU A 421;LEU A 422;MET A 368","None","1.08A","4xi3D-5ohjA:undetectable","4xi3D-5ohjA:17.70"],["5F8Y_A_X6XA202_1","GALNAC\/GAL-SPECIFIC LECTIN","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",5,"GLU A 585;VAL A 403;HIS A 406;ASP A 447;HIS A 479","None;None;None; MG A 700 ( 2.7A);None","1.19A","5f8yA-5ohjA:undetectable","5f8yA-5ohjA:20.51"],["5F8Y_B_X6XB201_1","GALNAC\/GAL-SPECIFIC LECTIN","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",5,"GLU A 585;VAL A 403;HIS A 406;ASP A 447;HIS A 479","None;None;None; MG A 700 ( 2.7A);None","1.21A","5f8yB-5ohjA:undetectable","5f8yB-5ohjA:20.51"],["5G6S_A_RAUA400_1","IMINE REDUCTASE;IMINE REDUCTASE","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",5,"LEU A 395;MET A 392;PHE A 388;MET A 368;GLY A 483","None","1.24A","5g6sA-5ohjA:undetectable;5g6sG-5ohjA:undetectable","5g6sA-5ohjA:12.54;5g6sG-5ohjA:12.54"],["5G6S_A_RAUA400_1","IMINE REDUCTASE;IMINE REDUCTASE","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",5,"LEU A 395;MET A 392;TYR A 391;MET A 368;GLY A 483","None","0.93A","5g6sA-5ohjA:undetectable;5g6sG-5ohjA:undetectable","5g6sA-5ohjA:12.54;5g6sG-5ohjA:12.54"],["5G6S_B_RAUB400_1","IMINE REDUCTASE;IMINE REDUCTASE","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",5,"LEU A 395;MET A 392;TYR A 391;MET A 368;GLY A 483","None","0.94A","5g6sB-5ohjA:undetectable;5g6sC-5ohjA:undetectable","5g6sB-5ohjA:12.54;5g6sC-5ohjA:12.54"],["5G6S_C_RAUC400_1","IMINE REDUCTASE;IMINE REDUCTASE","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",5,"MET A 368;GLY A 483;LEU A 395;MET A 392;PHE A 388","None","1.24A","5g6sB-5ohjA:undetectable;5g6sC-5ohjA:undetectable","5g6sB-5ohjA:12.54;5g6sC-5ohjA:12.54"],["5G6S_C_RAUC400_1","IMINE REDUCTASE;IMINE REDUCTASE","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",5,"MET A 368;GLY A 483;LEU A 395;MET A 392;TYR A 391","None","0.94A","5g6sB-5ohjA:undetectable;5g6sC-5ohjA:undetectable","5g6sB-5ohjA:12.54;5g6sC-5ohjA:12.54"],["5G6S_D_RAUD400_1","IMINE REDUCTASE;IMINE REDUCTASE","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",5,"LEU A 395;MET A 392;PHE A 388;MET A 368;GLY A 483","None","1.24A","5g6sD-5ohjA:undetectable;5g6sF-5ohjA:undetectable","5g6sD-5ohjA:12.54;5g6sF-5ohjA:12.54"],["5G6S_D_RAUD400_1","IMINE REDUCTASE;IMINE REDUCTASE","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",5,"LEU A 395;MET A 392;TYR A 391;MET A 368;GLY A 483","None","0.94A","5g6sD-5ohjA:undetectable;5g6sF-5ohjA:undetectable","5g6sD-5ohjA:12.54;5g6sF-5ohjA:12.54"],["5G6S_E_RAUE400_1","IMINE REDUCTASE;IMINE REDUCTASE","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",5,"LEU A 395;MET A 392;PHE A 388;MET A 368;GLY A 483","None","1.25A","5g6sE-5ohjA:undetectable;5g6sH-5ohjA:undetectable","5g6sE-5ohjA:12.54;5g6sH-5ohjA:12.54"],["5G6S_E_RAUE400_1","IMINE REDUCTASE;IMINE REDUCTASE","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",5,"LEU A 395;MET A 392;TYR A 391;MET A 368;GLY A 483","None","0.94A","5g6sE-5ohjA:undetectable;5g6sH-5ohjA:undetectable","5g6sE-5ohjA:12.54;5g6sH-5ohjA:12.54"],["5GTR_A_ESTA601_1","ESTROGEN RECEPTOR","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",5,"ALA A 563;LEU A 421;LEU A 422;MET A 368;ILE A 371","None","1.07A","5gtrA-5ohjA:3.2","5gtrA-5ohjA:17.70"],["5XDH_A_DAHA60_1","PUTATIVE CYTOCHROME C;PUTATIVE CYTOCHROME C","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",4,"HIS A 400;VAL A 453;LEU A 475;GLN A 589","None;None;None;9VE A 801 (-3.4A)","1.41A","5xdhA-5ohjA:undetectable;5xdhC-5ohjA:0.0","5xdhA-5ohjA:18.48;5xdhC-5ohjA:18.48"]]